Darifenacin: In the Treatment of Overactive Bladder

Author： Katherine F. Croom   Gillian M. Keating  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.13, 2004-01, pp. : 885-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darifenacin improves symptoms in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder

By Chapple Christopher R  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1493-1500

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano   Serati Maurizio   Bolis Pierfrancesco  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Imidafenacin for the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Scala Carolina   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1383-1397

Informa Healthcare

Access to resources Recommend Favorite

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Cardozo Linda   Ferrero Simone   Sileo Filomena   Cola Alice   Torella Marco   Colacurci Nicola   Candiani Massimo   Salvatore Stefano  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite